Etonitazene: an opioid selective for the mu receptor types

Area of Science:

• Pharmacology
• Neuroscience
• Receptor Binding Assays

Background:

• Opioid receptors (mu, delta, kappa) are critical targets for pain management.
• Morphine is a standard opioid analgesic, while etonitazene is a high-potency synthetic opioid.
• Understanding receptor affinity is key to predicting drug efficacy and side effects.

Purpose of the Study:

• To compare the binding affinities of morphine and etonitazene across multiple opioid and non-opioid receptor subtypes.
• To investigate the mu-1 receptor selectivity of both etonitazene and morphine.
• To correlate in vitro receptor binding data with known in vivo potencies.

Main Methods:

• Utilized specific radioligand binding protocols.
• Assessed binding affinity at mu-1, mu-2, delta, kappa-1, and sigma receptors.
• Compared etonitazene and morphine binding profiles.

Main Results:

• Both etonitazene and morphine exhibited a mu-1 selective binding profile.
• Etonitazene demonstrated a 2500-fold greater affinity for the mu-1 receptor compared to morphine.
• This significant difference in mu-1 affinity supports observed differences in behavioral potencies.

Conclusions:

• Etonitazene possesses markedly higher affinity for the mu-1 opioid receptor than morphine.
• The mu-1 receptor is a primary target for both etonitazene and morphine.
• Receptor binding data provide a strong basis for understanding the differential potencies of these opioids.